[18F]F-AraG

N/A

Report date: 2025/11/25 15:56:48

Base Information

Drug Name[18F]F-AraG
Drug Alias NameFlourine-18 F-AraGfluorine-18(18F)-radiolabeled-D-arabinofuranosylguanine2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanineFluorine F 18 Ara-GFlourine-18 labelled arabino furanosyl guanine +[13] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionDeoxycytidine kinase inhibitorsPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsDeoxycytidine kinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursGraft vs Host Disease +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California DavisStanford UniversityCellsight Technologies Inc +[7] 
Inactive CompaniesUniversity Of California San FranciscoUniversity Of CaliforniaUniversity Of Tennessee
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursGraft vs Host Disease +[9] 
Inactive IndicationsUrinary Bladder NeoplasmsLung NeoplasmsLymphoma, Non-Hodgkin +[4] 

Other Information

ATC CodeN/A
Related LinksN/A